FR

ZebraMENA-Microbiota

Tunisia | Biological Sciences

Swiss partners

  • CHUV/UNIL : Gilbert Greub (main applicant), Kin Ki Jim

 MENA partners

  • Université de Sfax : Radhouane Gdoura (main applicant), Randa Ben Akacha

Presentation of the project

Antibiotic-resistant bacterial infections (AMR) represent a critical health challenge in Tunisia and the MENA region, exacerbated by overconsumption of antibiotics, delayed diagnostics, and limited understanding of microbiota-pathogen interactions. This project proposes developing a zebrafish (Danio rerio) model to investigate the role of microbiota in pathogen virulence and AMR, with a focus on improving diagnostics and understanding resistance mechanisms through descriptive microbiota analysis.

The project aims to:

  1. establish a zebrafish model for studying microbiota-pathogen interactions and virulence mechanisms

  2. characterize how microbiota composition influences pathogen virulence and antibiotic resistance;

  3. develop rapid diagnostic tests based on microbiota-pathogen molecular signatures and in vivo readouts;

  4. build an annotated biobank of resistant clinical isolates with microbiota metadata, WGS, and resistome data.

The consortium brings together Prof. Gilbert Greub, Director of the Institute of Microbiology at CHUV (Lausanne, Switzerland), and Prof. Radhouane Gdoura, Director of the LR17ES06 Toxicology Environmental Microbiology and Health Research Laboratory at the Faculty of Sciences of Sfax (Sfax, Tunisia). Additionally, the project benefits from the partnership with the University of Lausanne, Dr. Kinki Jim (expertise in zebrafish infection modelling) and the Center of Biotechnology of Sfax (CBS), specifically Prof. Slim Tounsi, Prof. Sami Aifa, and Dr. Sami Mnif (responsible for the existing Zebrafish platform at CBS), which facilitates Zebrafish model development and experimental implementation. Through complementary expertise in clinical microbiology/genomics/zebrafish infection models (Switzerland) and microbiota omics/in vivo experimentation (Tunisia), and access to an established Zebrafish platform (CBS), the project produces diagnostic prototypes, standardized Zebrafish infection protocols with controlled microbiota, a biobank of annotated isolates, and strengthens MENA capacities in AMR surveillance and microbiota-based diagnostic research.